The federal government’s proposal to reclassify marijuana from Schedule 1 to Schedule 3 has sparked debate over its impact on drug testing, especially in safety-sensitive jobs. Schedule 1 drugs lack accepted medical use and have a high potential for abuse. The process for a Controlled Substance Act rule change could take a year, and approval would not automatically end the federal ban on marijuana.